Skip to content
Manufacture of pharmaceutical products
KZActiveBIN 141240007728
Plans from 2 000 ₸ a month
1/18
Some flags
Bad-faith public-procurement participant
To risks

ТОО "GENETECH"

Director
Маханбетов Али Нұрланұлы
Incorporated
08.12.2014
Address
Астана ул. БЕЙБІТШІЛІК, зд. 43
РНН
600300632421

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

1/18
Bad-faith public-procurement participantReview

Государственные закупки РК · data as of 10.11.2026

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "GENETECH"
BIN
141240007728
Status
Active
Director
Маханбетов Али Нұрланұлы
Registration date
08.12.2014
Activity
Производство лекарственных препаратов для ветеринарии
Legal address
Астана ул. БЕЙБІТШІЛІК, зд. 43

In government contracts over 2 years

VAT payer
Yes, since 15.02.2022
КАТО
711310000
РНН
600300632421
КФС
Собственность совместных предприятий с иностранным участием
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 6 до 10 чел.

Has changed

Procurement role
Поставщик

Activities

4
21202primary

Производство лекарственных препаратов для ветеринарии

Secondary

  • 46462Оптовая реализация фармацевтических и медицинских товаров в рамках гарантированного объема бесплатной медицинской помощи
  • 72110Научные исследования и экспериментальные разработки в области биотехнологий
  • 72199Прочие исследования и разработки в области естественных и технических наук
Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
9.5M
2025
17.8M+18%
2024
15.2M-23%
2023
19.7M+256%
2022
5.5M+12438%
2021
44K
·9.5M
2026year to date
+18%17.8M
2025
-23%15.2M
2024
+256%19.7M
2023
+12438%5.5M
2022
·44K
2021
2026
Tax paid9,545,100 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid17,807,778 ₸
Penalty52,000 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid15,153,396 ₸
Penalty32,000 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid19,653,460 ₸
Penalty440,000 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid5,516,607 ₸
Penalty82,500 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid44,000 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • МА

    Маханбетов Али Нұрланұлы

    Director

Former directors

  • МАМАХАНБЕТОВА АЙЖАРКЫН НУРЛАНОВНА
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "GENETECH" (BIN 141240007728): Active legal entity, Astana, registered in 2014, 12 years on the market. Primary classifier activity: manufacture of pharmaceutical products. Besides the main one, 3 activities are registered. Size: small enterprise, staff of 6 to 10. In 2025, 17.8M ₸ was paid into the budget in taxes. Government contracts: 651 contracts as a supplier, total value 1.1B ₸; the latest contract was signed in 2025. Screening flagged 1 risk indicator: bad-faith public-procurement participant. The latest change to registration data: change in activities (September 1, 2026). Structure on record: 1 founder. Director on record: Маханбетов Али Нұрланұлы. Registry data current as of September 1, 2026.

Data sources and disclaimer

Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.